Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for March 2026

Showing all data including statistical outliers.Hide Outliers
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
37,088
% of Holdings
0.9%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
37,417
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
37,809
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
38,067
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Tanguler Tolga โ€” EVP, Chief Commercial Officer
Mar 2, 2026
Sale
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
38,157
% of Holdings
0.1%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
40,000
Price
$1.25
Total Value
$50.04K
Shares Held After
322,543
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
26,930
Price
$1.25
Total Value
$33.69K
Shares Held After
218,445
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
357,500
Price
$1.25
Total Value
$447.27K
Shares Held After
2,900,642
% of Holdings
11.0%

US ENERGY CORP (USEG)

Batchelor Joshua Lane โ€” 10% Owner
Mar 2, 2026
Sale
Shares
10,400
Price
$1.25
Total Value
$13.01K
Shares Held After
84,663
% of Holdings
10.9%
Mar 2, 2026
Sale
Shares
160
Price
$332.64
Total Value
$53.22K
Shares Held After
98,628
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
399
Price
$331.93
Total Value
$132.44K
Shares Held After
98,788
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
346
Price
$330.85
Total Value
$114.47K
Shares Held After
99,187
% of Holdings
0.3%
Mar 2, 2026
Sale
Shares
722
Price
$329.71
Total Value
$238.05K
Shares Held After
99,533
% of Holdings
0.7%
Mar 2, 2026
Sale
Shares
424
Price
$328.71
Total Value
$139.37K
Shares Held After
100,255
% of Holdings
0.4%
Mar 2, 2026
Sale
Shares
1,399
Price
$327.67
Total Value
$458.41K
Shares Held After
100,679
% of Holdings
1.4%
Mar 2, 2026
Sale
Shares
1,669
Price
$326.81
Total Value
$545.45K
Shares Held After
102,078
% of Holdings
1.6%
Mar 2, 2026
Sale
Shares
1,098
Price
$325.63
Total Value
$357.54K
Shares Held After
103,747
% of Holdings
1.0%
Mar 2, 2026
Sale
Shares
382
Price
$324.65
Total Value
$124.02K
Shares Held After
104,845
% of Holdings
0.4%

ALKAMI TECHNOLOGY, INC. (ALKT)

Sachdeva Prerna โ€” Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,352
Price
$16.90
Total Value
$22.85K
Shares Held After
63,608
% of Holdings
2.1%
Mar 2, 2026
Sale
Shares
200
Price
$323.62
Total Value
$64.72K
Shares Held After
105,227
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
23,512
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
23,549
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%

ALKAMI TECHNOLOGY, INC. (ALKT)

Linebarger Douglas A. โ€” Chief Legal Officer
Mar 2, 2026
Sale
Shares
5,518
Price
$16.90
Total Value
$93.25K
Shares Held After
216,233
% of Holdings
2.5%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
4,198
Price
$1.43
Total Value
$6.00K
Shares Held After
170,736
% of Holdings
2.4%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
2,461
Price
$1.43
Total Value
$3.52K
Shares Held After
174,934
% of Holdings
1.4%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
3,068
Price
$1.43
Total Value
$4.39K
Shares Held After
177,395
% of Holdings
1.7%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
756
Price
$1.43
Total Value
$1.08K
Shares Held After
180,463
% of Holdings
0.4%
Mar 2, 2026
Purchase
Shares
1,000
Price
$30.00
Total Value
$30.00K
Shares Held After
21,522
% of Holdings
4.6%

Penumbra Inc (PEN)

Yuen Maggie โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
2,432
Price
$342.30
Total Value
$832.47K
Shares Held After
18,353
% of Holdings
11.7%
Mar 2, 2026
Purchase
Shares
500
Price
$30.12
Total Value
$15.06K
Shares Held After
20,522
% of Holdings
2.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
Version: v26.3.33